Eagle Health Investments’s AstraZeneca AZN Stock Holding History

Eagle Health Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-188,983	Closed	-$20.7M	–	28
2022 Q3	$20.7M	Sell	188,983 -2,550	-1%	-$323K	4.76%	12
2022 Q2	$25.3M	Sell	191,533 -31,300	-14%	-$4.11M	5.9%	5
2022 Q1	$29.6M	Sell	222,833 -83,000	-27%	-$9.95M	7.28%	3
2021 Q4	$35.6M	Buy	305,833 +81,050	+36%	+$9.54M	8.68%	2
2021 Q3	$27M	Buy	224,783 +24,888	+12%	+$2.9M	8.56%	1
2021 Q2	$23.9M	Buy	199,895 +21,500	+12%	+$2.36M	8.22%	1
2021 Q1	$17.7M	Buy	178,395 +63,345	+55%	+$6.37M	6.96%	5
2020 Q4	$11.5M	Buy	+115,050	New	+$12.2M	7.36%	5

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Eagle Health Investments's AZN Position: Q4 2022 in Review

Eagle Health Investments sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 188,983 shares — an estimated $20.7M sold.

Eagle Health Investments first reported a position in AZN in Q4 2020 and held it in 8 quarters. The position peaked at $35.6M in Q4 2021. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Eagle Health Investments reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
Eagle Health Investments sold 188,983 AstraZeneca shares in Q4 2022, an estimated $20.7M.
Eagle Health Investments first reported a position in AstraZeneca in Q4 2020 and held it in 8 quarters.
Eagle Health Investments's AstraZeneca position peaked at $35.6M in Q4 2021.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Eagle Health Investments's 13F filing for Q4 2022, filed 13 Feb 2023.